Literature DB >> 19082928

Why and when PCI, why and when thrombolysis?: PCI.

Maddalena Lettino1.   

Abstract

Mesh：

Year:  2008        PMID： 19082928     DOI： 10.1007/s11739-008-0212-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  12 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

Review 3.  Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options.

Authors:  William E Boden; Kim Eagle; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2007-08-21       Impact factor: 24.094

4.  Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.

Authors:  Ulf Stenestrand; Johan Lindbäck; Lars Wallentin
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

5.  Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.

Authors:  Giuseppe De Luca; Harry Suryapranata; Jan Paul Ottervanger; Elliott M Antman
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

6.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

Review 7.  Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.

Authors:  C Grines; A Patel; F Zijlstra; W D Weaver; C Granger; R J Simes
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

Authors:  M Dalby; A Bouzamondo; P Lechat; G Montalescot
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
View more
  1 in total

Review 1.  Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.

Authors:  Giuseppe Di Pasquale; Elisa Filippini; Pier Camillo Pavesi; Gianfranco Tortorici; Gianni Casella; Pietro Sangiorgio
Journal:  Intern Emerg Med       Date:  2016-03-07       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.